Abstract:MicroRNAs (miRNAs) act as important gene regulators in human genomes and their aberrant expression links to many malignancies. We previously identified a different characteristic miRNA expression profile in cervical cancer from that in cervical normal tissues, including the downregulated miR-424. However, the role and mechanism of miR-424 in cervical cancer still remain unknown. Here, we focused on identifying the tumor-suppressive function and clinical significance of miR-424 and exploring the mechanistic relevance by characterizing its target. We showed a significantly decreased expression of miR-424 in 147 cervical cancer tissues versus 74 cervical normal tissues by performing quantitative RT–PCR. In 147 cervical cancer tissue samples, low-level expression of miR-424 was positively correlated with poor tumor differentiation, advanced clinical stage, lymph node metastasis and other poor prognostic clinicopathological parameters. Further in vitro observations showed that enforced expression of miR-424 inhibited cell growth by both enhancing apoptosis and blocking G1/S transition, and suppressed cell migration and invasion in two human cervical cancer cell lines, SiHa and CaSki, implying that miR-424 functions as a tumor suppressor in the progression of cervical cancer. Interestingly, overexpression of miR-424 inhibited the expression of protein checkpoint kinase 1 (Chk1) and phosphorylated Chk1 (p-Chk1) at residues Ser345 and decreased the activity of luciferase-reporter containing the 3′-untranslated region (UTR) of Chk1 with predicted miR-424-binding site. Moreover, miR-424 expression levels were inversely correlated with Chk1 and p-Chk1 protein levels in both cervical cancer and normal tissues. Furthermore, RNAi-mediated knockdown of Chk1 decreased matrix metalloproteinase 9 expression and phenocopied the tumor suppressive effects of miR-424 in cell models. Taken together, our results identify a crucial tumor suppressive role of miR-424 in the progression of cervical cancer at least partly via upreglating the expression of Chk1 and p-Chk1, and suggest that miR-424 might be a candidate of prognostic predictor or an anticancer therapeutic target for cervical cancer patients.

Mir-182 Induces Cervical Cancer Cell Apoptosis Through Inhibiting the Expression of DNMT3a.

Suppressed Mir-424 Expression Via Upregulation of Target Gene Chk1 Contributes to the Progression of Cervical Cancer

Micro ribonucleic acid-93 promotes oncogenesis of cervical cancer by targeting RAB11 family interacting protein 1.

MiR-634 Decreases Cell Proliferation and Induces Apoptosis by Targeting Mtor Signaling Pathway in Cervical Cancer Cells

Mir-141-5p Affects the Cell Proliferation and Apoptosis by Targeting BTG1 in Cervical Cancer

Mir-130A-3p Promotes Cell Proliferation and Invasion by Targeting Estrogen Receptor Α and Androgen Receptor in Cervical Cancer.

Mir-187 Induces Apoptosis of SiHa Cervical Carcinoma Cells by Downregulating Bcl-2.

Mir-375 is Down-Regulated in Squamous Cervical Cancer and Inhibits Cell Migration and Invasion Via Targeting Transcription Factor SP1

Mir-454-3p Promotes Proliferation and Induces Apoptosis in Human Cervical Cancer Cells by Targeting TRIM3

Mir-187 Inhibits the Growth of Cervical Cancer Cells by Targeting FGF9

Mir-187 Overexpression Inhibits Cervical Cancer Progression by Targeting Hpv16 E6

[Mir-182 Promotes Cell Proliferation of Cervical Cancer Cells by Targeting Adenomatous Polyposis Coli (APC) Gene].

Role and Mechanism of Mir-4778-3p and Its Targets NR2C2 and Med19 in Cervical Cancer Radioresistance.

DNA methylation of miR-138 regulates cell proliferation and EMT in cervical cancer by targeting EZH2

HIF-3α-Induced Mir-630 Expression Promotes Cancer Hallmarks in Cervical Cancer Cells by Forming a Positive Feedback Loop

DNMT1 Recruited by EZH2-mediated Silencing of Mir-484 Contributes to the Malignancy of Cervical Cancer Cells Through MMP14 and HNF1A

Effect of Mirna-203 on Cervical Cancer Cells and Its Underlying Mechanism.

Mir-375 Is Epigenetically Downregulated By Hpv-16 E6 Mediated Dnmt1 Upregulation And Modulates Emt Of Cervical Cancer Cells By Suppressing Lncrna Malat1

miR-186-3p attenuates the tumorigenesis of cervical cancer via targeting insulin-like growth factor 1 to suppress PI3K-Akt signaling pathway

N<SUP>6</SUP>-Methyladenosine Associated Silencing of miR-193b Promotes Cervical Cancer Aggressiveness by Targeting CCND1

Mir-203a-5p Suppresses Cervical Cancer Cell Tumorigenesis And Emt Via Targeting Mapk1